$43.82-0.26 (-0.59%)
Monster Beverage Corporation, through its subsidiaries, engages in development, marketing, sale, and distribution of energy drink beverages and concentrates in the United States and internationally.
Monster Beverage Corporation in the Consumer Defensive sector is trading at $43.82 with a market capitalization of $85.8B. Wall Street consensus targets $50.26 (23 analysts), implying a +14.7% move over the next 12 months. The stock is currently 13% below its 52-week high of $50.17, remaining 4.9% above its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $2.54B↑ | $2.35B↑ | $2.13B↓ | $2.20B↑ | $2.11B |
| Gross Profit | $1.42B↑ | $1.29B↑ | $1.18B↓ | $1.22B↑ | $1.18B |
| Operating Income | $740.44M↑ | $729.96M↑ | $542.63M↓ | $675.35M↑ | $631.62M |
| Net Income | $584.54M↑ | $569.49M↑ | $449.19M↓ | $524.46M↑ | $488.79M |
Monster Beverage Corporation, through its subsidiaries, engages in development, marketing, sale, and distribution of energy drink beverages and concentrates in the United States and internationally. The company operates through four segments: Monster...

Monster Beverage is growing rapidly, and investors are well aware of it.

Monster Beverage has rallied the S&P 500 Index over the past year, and analysts remain somewhat bullish about the stock’s growth prospects.

The high-growth coffee chain is executing its playbook, but a look at the stock’s past performance after similar drops tells a more complicated story.

Monster trades at $44.36 and has moved in lockstep with the market. Its shares have returned 12.3% over the last six months while the S&P 500 has gained 12%.

MNST's energy drink momentum, product innovation and global expansion support growth, while pricing actions and valuation remain key watchpoints.
Academic risk and quality models computed from MNST's own filings and price history, not from analyst opinion.
Mixed: 6 of 9 fundamental-health tests pass, so profitability and balance-sheet trends disagree.
Altman Z above the 2.99 safe threshold, so the model puts bankruptcy risk in its lowest band.
Beneish M below the -1.78 flag threshold, so the earnings-manipulation model finds nothing unusual in the accruals and margin trends.
The stock’s own historical valuation anchor, which is a fairer comparison than a sector average for a company with a persistent premium or discount.